Cargando…
The effect of Chinese herbs and its effective components on coronary heart disease through PPARs-PGC1α pathway
BACKGROUND: DanQi pill (DQP) is prescribed widely in China and has definite cardioprotective effect on coronary heart disease. Our previous studies proved that DQP could effectively regulate plasma levels of high density lipoprotein (HDL) and low density lipoprotein (LDL). However, the regulatory me...
Autores principales: | Wang, Qiyan, Li, Chun, Zhang, Qian, Wang, Yuanyuan, Shi, Tianjiao, Lu, Linghui, Zhang, Yi, Wang, Yong, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153825/ https://www.ncbi.nlm.nih.gov/pubmed/27955667 http://dx.doi.org/10.1186/s12906-016-1496-z |
Ejemplares similares
-
Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease
por: Chang, Hong, et al.
Publicado: (2016) -
Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway
por: Zhang, Qian, et al.
Publicado: (2020) -
Protective Effects of Acyl-coA Thioesterase 1 on Diabetic Heart via PPARα/PGC1α Signaling
por: Yang, Shenglan, et al.
Publicado: (2012) -
A Review of Chinese Herbal Medicine for the Treatment of Chronic Heart Failure
por: Wang, Yong, et al.
Publicado: (2017) -
PGC-1α Protects against Hepatic Ischemia Reperfusion Injury by Activating PPARα and PPARγ and Regulating ROS Production
por: Wang, Chaoqun, et al.
Publicado: (2021)